|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Gross premiums written | |||||
| Net premiums written | |||||
| Change in unearned premiums | |||||
| Net premiums earned | |||||
| Other insurance revenue (expense), net | |||||
| Other insurance (expense) revenue, net | |||||
| Net investment income | |||||
| Net realized and unrealized investment gains | |||||
| Total revenues | |||||
| Expenses | |||||
| Net loss and loss adjustment expenses | |||||
| Commission and other acquisition expenses | |||||
| General and administrative expenses | |||||
| Interest and amortization expenses | |||||
| Foreign exchange and other (gains) losses | |||||
| Total expenses | |||||
| Loss before income taxes and interest in income of equity method investments | |||||
| Less: Income tax expense | |||||
| Interest in income of equity method investments | |||||
| Net loss | |||||
| Gain from repurchase of preference shares | |||||
| Gain from repurchase and exchange of preference shares | |||||
| Net (loss) income (attributable) available to Maiden common shareholders, basic | |||||
| Basic loss per share attributable to common shareholders (in dollars per share) | |||||
| Diluted loss per share attributable to common shareholders (in dollars per share) | |||||
| Weighted average number of common shares - basic (in shares) | |||||
| Weighted average number of common shares - diluted (in shares) | |||||
Loading...